Pei, Yuanyuan <br/><br/>
Sequential Targeting TGF-β Signaling and KRAS Mutation Increases Therapeutic Efficacy in Pancreatic Cancer.  [electronic resource] 

 -  Small (Weinheim an der Bergstrasse, Germany)  06 2019 
 - e1900631 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1613-6829 
<br/><br/><label>Standard No.: </label>10.1002/smll.201900631  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Apolipoprotein E3--genetics<br/>Benzofurans--administration & dosage<br/>Drug Administration Schedule<br/>Drug Carriers--administration & dosage<br/>Gene Expression Regulation, Neoplastic--drug effects<br/>Humans<br/>Mice<br/>Mice, Nude<br/>Molecular Targeted Therapy--methods<br/>Mutation--drug effects<br/>NIH 3T3 Cells<br/>Nanoparticles--administration & dosage<br/>Pancreatic Neoplasms--drug therapy<br/>Peptide Fragments--administration & dosage<br/>Proto-Oncogene Proteins p21(ras)--antagonists & inhibitors<br/>RNA, Small Interfering--administration & dosage<br/>Signal Transduction--drug effects<br/>Transforming Growth Factor beta--drug effects<br/>Tumor Cells, Cultured<br/>Xenograft Model Antitumor Assays